NK

NantKwest
NASDAQ

实时行情|Nasdaq Last Sale

6.07
+0.13
+2.19%
已收盘, 16:57 02/19 EST
开盘
6.01
昨收
5.94
最高
6.19
最低
5.70
成交量
87.03万
成交额
--
52周最高
9.90
52周最低
0.9500
市值
5.97亿
市盈率(TTM)
-7.9170
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

NK 新闻

  • 三只股票成“派息大户”,投资者稳赚不亏?
  • 新浪财经-自媒体综合.20分钟前
  • 福布斯发布区块链50强:蚂蚁金服、腾讯、百度等上榜
  • TechWeb.43分钟前
  • 英伟达数据中心业务2020财年营收接近30亿美元
  • TechWeb.48分钟前
  • 苹果二次复兴:大象又开始跳舞了
  • 界面新闻.1小时前

更多

所属板块

生物技术和医学研究
+1.01%
制药与医学研究
+0.22%

热门股票

名称
价格
涨跌幅

NK 简况

NantKwest, Inc. is a clinical-stage immunotherapy company. The Company is focused on harnessing the power of the innate immune system by using the natural killer cell to treat cancer, infectious diseases and inflammatory diseases. Its immuno-oncology NK platform has multiple modes to induce cell death against the tumor or infected cell by direct killing by binding to stress ligands expressed by the diseased cell with the release of toxic granules directly into the tumor cell; antibody mediated killing by binding to antibodies administered in combination and enhancing the cancer killing effect of the administered antibody, enabling targeted cell killing through antibody dependent cellular cytotoxicity (ADCC), and target activated killing by binding to known or newly discovered tumor-specific antigens expressed on the surface of tumor cells and inducing cell death by the release of toxic granules directly into the tumor cell and by the release of cytokines and chemokines.
展开

Webull提供Nantkwest Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。